This pipeline uses various statistical tests to identify selected clinical features related to mutation rate.
Testing the association between 2 variables and 15 clinical features across 276 samples, statistically thresholded by P value < 0.05 and Q value < 0.3, 4 clinical features related to at least one variables.
-
2 variables correlated to 'AGE_mutation.rate'.
-
MUTATIONRATE_NONSYNONYMOUS , MUTATIONRATE_SILENT
-
1 variable correlated to 'MELANOMA.ULCERATION'.
-
MUTATIONRATE_SILENT
-
2 variables correlated to 'GENDER'.
-
MUTATIONRATE_NONSYNONYMOUS , MUTATIONRATE_SILENT
-
2 variables correlated to 'RACE'.
-
MUTATIONRATE_NONSYNONYMOUS , MUTATIONRATE_SILENT
-
No variables correlated to 'Time from Specimen Diagnosis to Death', 'Time to Death', 'AGE', 'PRIMARY.SITE.OF.DISEASE', 'NEOPLASM.DISEASESTAGE', 'PATHOLOGY.T.STAGE', 'PATHOLOGY.N.STAGE', 'PATHOLOGY.M.STAGE', 'MELANOMA.PRIMARY.KNOWN', 'BRESLOW.THICKNESS', and 'ETHNICITY'.
Complete statistical result table is provided in Supplement Table 1
Clinical feature | Statistical test | Significant variables | Associated with | Associated with | ||
---|---|---|---|---|---|---|
Time from Specimen Diagnosis to Death | Cox regression test | N=0 | ||||
Time to Death | Cox regression test | N=0 | ||||
AGE | Spearman correlation test | N=0 | ||||
AGE | Linear Regression Analysis | N=2 | ||||
PRIMARY SITE OF DISEASE | Kruskal-Wallis test | N=0 | ||||
NEOPLASM DISEASESTAGE | Kruskal-Wallis test | N=0 | ||||
PATHOLOGY T STAGE | Spearman correlation test | N=0 | ||||
PATHOLOGY N STAGE | Spearman correlation test | N=0 | ||||
PATHOLOGY M STAGE | Kruskal-Wallis test | N=0 | ||||
MELANOMA ULCERATION | Wilcoxon test | N=1 | yes | N=1 | no | N=0 |
MELANOMA PRIMARY KNOWN | Wilcoxon test | N=0 | ||||
BRESLOW THICKNESS | Spearman correlation test | N=0 | ||||
GENDER | Wilcoxon test | N=2 | male | N=2 | female | N=0 |
RACE | Kruskal-Wallis test | N=2 | ||||
ETHNICITY | Wilcoxon test | N=0 |
No variable related to 'Time from Specimen Diagnosis to Death'.
Time from Specimen Diagnosis to Death | Duration (Months) | 0.1-125.7 (median=16.9) |
censored | N = 126 | |
death | N = 140 | |
Significant variables | N = 0 |
Time to Death | Duration (Months) | 0.2-357.4 (median=51.8) |
censored | N = 129 | |
death | N = 141 | |
Significant variables | N = 0 |
AGE | Mean (SD) | 55.82 (16) |
Significant variables | N = 0 |
AGE | Mean (SD) | 55.82 (16) |
Significant variables | N = 2 |
PRIMARY.SITE.OF.DISEASE | Labels | N |
DISTANT METASTASIS | 39 | |
PRIMARY TUMOR | 5 | |
REGIONAL CUTANEOUS OR SUBCUTANEOUS TISSUE | 60 | |
REGIONAL LYMPH NODE | 171 | |
Significant variables | N = 0 |
NEOPLASM.DISEASESTAGE | Labels | N |
I OR II NOS | 10 | |
STAGE 0 | 6 | |
STAGE I | 24 | |
STAGE IA | 10 | |
STAGE IB | 24 | |
STAGE II | 16 | |
STAGE IIA | 10 | |
STAGE IIB | 14 | |
STAGE IIC | 9 | |
STAGE III | 32 | |
STAGE IIIA | 13 | |
STAGE IIIB | 23 | |
STAGE IIIC | 46 | |
STAGE IV | 16 | |
Significant variables | N = 0 |
PATHOLOGY.T.STAGE | Mean (SD) | 2.42 (1.3) |
N | ||
0 | 22 | |
1 | 30 | |
2 | 59 | |
3 | 54 | |
4 | 57 | |
Significant variables | N = 0 |
PATHOLOGY.N.STAGE | Mean (SD) | 0.87 (1.1) |
N | ||
0 | 139 | |
1 | 48 | |
2 | 33 | |
3 | 36 | |
Significant variables | N = 0 |
PATHOLOGY.M.STAGE | Labels | N |
M0 | 244 | |
M1 | 4 | |
M1A | 3 | |
M1B | 2 | |
M1C | 8 | |
Significant variables | N = 0 |
MELANOMA.ULCERATION | Labels | N |
NO | 103 | |
YES | 68 | |
Significant variables | N = 1 | |
Higher in YES | 1 | |
Higher in NO | 0 |
W(pos if higher in 'YES') | wilcoxontestP | Q | AUC | |
---|---|---|---|---|
MUTATIONRATE_SILENT | 2871 | 0.0466 | 0.0932 | 0.5901 |
MELANOMA.PRIMARY.KNOWN | Labels | N |
NO | 36 | |
YES | 239 | |
Significant variables | N = 0 |
BRESLOW.THICKNESS | Mean (SD) | 3.61 (5) |
Significant variables | N = 0 |
GENDER | Labels | N |
FEMALE | 106 | |
MALE | 170 | |
Significant variables | N = 2 | |
Higher in MALE | 2 | |
Higher in FEMALE | 0 |
RACE | Labels | N |
ASIAN | 3 | |
BLACK OR AFRICAN AMERICAN | 1 | |
WHITE | 272 | |
Significant variables | N = 2 |
-
Expresson data file = SKCM-TM.patients.counts_and_rates.txt
-
Clinical data file = SKCM-TM.merged_data.txt
-
Number of patients = 276
-
Number of variables = 2
-
Number of clinical features = 15
For survival clinical features, Wald's test in univariate Cox regression analysis with proportional hazards model (Andersen and Gill 1982) was used to estimate the P values using the 'coxph' function in R. Kaplan-Meier survival curves were plot using the four quartile subgroups of patients based on expression levels
For continuous numerical clinical features, Spearman's rank correlation coefficients (Spearman 1904) and two-tailed P values were estimated using 'cor.test' function in R
For multi-class clinical features (ordinal or nominal), one-way analysis of variance (Howell 2002) was applied to compare the log2-expression levels between different clinical classes using 'anova' function in R
For two-class clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the log2-expression levels between the two clinical classes using 't.test' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.